1. Home
  2. CSTE vs ATNM Comparison

CSTE vs ATNM Comparison

Compare CSTE & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$1.85

Market Cap

61.9M

Sector

Industrials

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.40

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
ATNM
Founded
1987
2000
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.9M
50.2M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
CSTE
ATNM
Price
$1.85
$1.40
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$4.00
AVG Volume (30 Days)
536.2K
194.8K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$400,656,000.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
$42,943.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.11
52 Week Low
$0.86
$1.03
52 Week High
$5.04
$2.41

Technical Indicators

Market Signals
Indicator
CSTE
ATNM
Relative Strength Index (RSI) 71.24 51.02
Support Level $0.86 $1.33
Resistance Level $1.94 $1.54
Average True Range (ATR) 0.20 0.09
MACD 0.10 0.01
Stochastic Oscillator 92.08 56.90

Price Performance

Historical Comparison
CSTE
ATNM

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: